Genbank References: capsid (p24)

HOME Genotype-Rx Genotype-Pheno Genotype-Clinical hivdb program

Genbank References: capsid (p24)

Authors	Title	Citation	E-value	# in Gb	#Pts	ART	Source	Cloning	StudyType
Rolland (2017)	Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial	Nat. Med. 17 (3), 366-371 (2011)	9.24e-158	442	68	Naive	Plasma	SGS	Molecular epidemiology

Download sequences

Accession	IsolateName	Country	Coll Date	MolType	Source	Note	FirstAA	LastAA	MutList
JF320159	502-0006_LH01	USA	Sep-2006	genomic RNA	plasma from male placebo recipient502-0006	subtype: B	1	231	14P,83L,116A,128D,154K,171I,186A
JF320617	502-0053_wg01	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0053	subtype: B	1	231	6M,14P,91V,216S,225S
JF320618	502-0053_wg02	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0053	subtype: B	1	231	6M,14P,91V,216S,225S
JF320623	502-0053_wg03	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0053	subtype: B	1	231	6M,14P,91V,216S,225S
JF320624	502-0053_wg04	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0053	subtype: B	1	231	6M,14P,91V,216S,225S
JF320626	502-0053_wg05	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0053	subtype: B	1	231	6M,14P,91V,216S,225S
JF320615	502-0053_wg06	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0053	subtype: B	1	231	6M,14P,91V,216S,225S
JF320627	502-0053_wg07	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0053	subtype: B	1	231	6M,14P,91V,216S,225S
JF320625	502-0053_wg08	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0053	subtype: B	1	231	6M,14P,91V,216S,225S
JF320621	502-0053_wg09	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0053	subtype: B	1	231	6M,14P,91V,216S,225S
JF320620	502-0053_wg10	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0053	subtype: B	1	231	6M,14P,91V,216S,225S
JF320629	502-0062_FL01	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0062	subtype: B	1	231	6L,15L,41T,83L,120H,136M,154K,178T,208G,225A
JF320616	502-0062_FL02	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0062	subtype: B	1	231	6L,15L,41T,83L,120H,136M,154K,178T,208G,225A
JF320628	502-0062_FL03	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0062	subtype: B	1	231	6L,15L,41T,83L,120H,136M,154K,178T,208G,225A
JF320613	502-0062_FL04	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0062	subtype: B	1	231	6L,15L,41T,83L,120H,136M,154K,178T,208G,225A
JF320622	502-0062_FL05	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0062	subtype: B	1	231	6L,15L,41T,83L,120H,136M,154K,178T,208G,225A
JF320619	502-0062_FL06	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0062	subtype: B	1	231	6L,15L,41T,83L,120H,136M,154K,178T,208G,225A
JF320516	502-0176_FL01	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320365	502-0176_FL02	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320518	502-0176_FL03	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320374	502-0176_FL04	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320519	502-0176_FL05	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320363	502-0176_FL06	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320515	502-0176_FL07	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320364	502-0176_FL09	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320366	502-0176_FL10	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320514	502-0176_LH01	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320373	502-0176_LH02	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320369	502-0176_LH03	USA	Oct-2006	genomic RNA	plasma from male placebo recipient502-0176	subtype: B	1	231	4R,6L,10L,11T,83L,116D,136M,154K
JF320059	502-0223_wg1	USA	Oct-2005	genomic RNA	plasma from male placebo recipient502-0223	subtype: B	1	231	6L,14P,17A,41T,83L,116A,124V,180D,208G,210S,225S
JF320253	502-0227_FL02	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A
JF320256	502-0227_FL03	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A
JF320036	502-0227_FL05	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A,208G
JF320247	502-0227_FL06	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A,208G
JF320257	502-0227_FL07	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A
JF320251	502-0227_FL08	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A,208G
JF320255	502-0227_FL09	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A,208G
JF320250	502-0227_FL10	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A
JF320254	502-0227_LH01	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A,208G
JF320037	502-0227_LH02	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A,208G
JF320246	502-0227_LH03	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0227	subtype: B	1	231	14P,79D,83L,91V,148A,208G
JF320408	502-0287_LH1	USA	Apr-2007	genomic RNA	plasma from male vaccine recipient502-0287	subtype: B	1	231	6L,27I,83L,91V,148I,225S,230I
JF320400	502-0287_LH2	USA	Apr-2007	genomic RNA	plasma from male vaccine recipient502-0287	subtype: B	1	231	6L,27I,83L,91V,148I,225S,230I
JF320397	502-0287_LH3	USA	Apr-2007	genomic RNA	plasma from male vaccine recipient502-0287	subtype: B	1	231	6L,27I,83L,91V,148I,225S,230I
JF320396	502-0287_LH4	USA	Apr-2007	genomic RNA	plasma from male vaccine recipient502-0287	subtype: B	1	231	6L,27I,83L,91V,148I,225S,230I
JF320395	502-0287_LH5	USA	Apr-2007	genomic RNA	plasma from male vaccine recipient502-0287	subtype: B	1	231	6L,27I,83L,91V,148I,225S,230I
JF320056	502-0309_wg02	USA	Oct-2006	genomic RNA	plasma from male vaccine recipient502-0309	subtype: B	1	231	6L,83L,110N,154K
JF320071	502-0309_wg04	USA	Oct-2006	genomic RNA	plasma from male vaccine recipient502-0309	subtype: B	1	231	6L,83L,110N,154K
JF320068	502-0309_wg12	USA	Oct-2006	genomic RNA	plasma from male vaccine recipient502-0309	subtype: B	1	231	6L,83L,110N,154K
JF320048	502-0309_wg13	USA	Oct-2006	genomic RNA	plasma from male vaccine recipient502-0309	subtype: B	1	231	6L,83L,110N,154K
JF320065	502-0309_wg14	USA	Oct-2006	genomic RNA	plasma from male vaccine recipient502-0309	subtype: B	1	231	6L,83L,110N,154K
JF320307	502-0322_LH01	USA	Sep-2006	genomic RNA	plasma from male placebo recipient502-0322	subtype: B	1	231	6L,83L,128D,154K,171I,177C,180D
JF320309	502-0322_LH02	USA	Sep-2006	genomic RNA	plasma from male placebo recipient502-0322	subtype: B	1	231	6L,83L,128D,154K,171I,177C,180D
JF320311	502-0322_LH03	USA	Sep-2006	genomic RNA	plasma from male placebo recipient502-0322	subtype: B	1	231	6L,83L,128D,154K,171I,177C,180D
JF320082	502-0341_FL03	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-0341	subtype: B	1	231	6L,83L,154K,171I
JF320005	502-0341_FL04	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-0341	subtype: B	1	231	6L,83L,154K,171I
JF320003	502-0341_FL05	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-0341	subtype: B	1	231	6L,83L,154K,171I
JF320081	502-0341_FL06	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-0341	subtype: B	1	231	6L,83L,154K,171I
JF320006	502-0341_FL07	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-0341	subtype: B	1	231	6L,83L,154K,171I
JF320092	502-0346_LH01	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0346	subtype: B	1	231	6L,83L,86A,87Q,96I,116T
JF320087	502-0346_LH02	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0346	subtype: B	1	231	6L,83L,86A,87Q,96I,116T
JF320091	502-0346_LH03	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0346	subtype: B	1	231	6L,83L,86A,87Q,96I,116T
JF320088	502-0346_LH04	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0346	subtype: B	1	231	6L,83L,86A,87Q,96I,116T
JF320093	502-0346_LH05	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0346	subtype: B	1	231	6L,83L,86A,87Q,96I,116T
JF320086	502-0346_LH06	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0346	subtype: B	1	231	6L,83L,86A,87Q,96I,116T
JF320084	502-0346_LH07	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0346	subtype: B	1	231	6L,83L,86A,87Q,96I,116T
JF320098	502-0346_wg01	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0346	subtype: B	1	231	6L,83L,86A,87Q,96I,116T
JF320097	502-0346_wg02	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0346	subtype: B	1	231	6L,83L,86A,87Q,96I,116T
JF320562	502-0364_wg1	USA	Feb-2007	genomic RNA	plasma from male placebo recipient502-0364	subtype: B	1	231	6V,27I,41T,68I,75D,83T,91V,120H,128D,180D,208G,225A
JF320563	502-0364_wg2	USA	Feb-2007	genomic RNA	plasma from male placebo recipient502-0364	subtype: B	1	231	6V,27I,41T,68I,75D,83T,91V,120H,128D,180D,208G,225A
JF320560	502-0364_wg3	USA	Feb-2007	genomic RNA	plasma from male placebo recipient502-0364	subtype: B	1	231	6V,27I,41T,68I,75D,83T,91V,120H,128D,180D,208G,225A
JF320561	502-0364_wg4	USA	Feb-2007	genomic RNA	plasma from male placebo recipient502-0364	subtype: B	1	231	6V,27I,41T,68I,75D,83T,91V,120H,128D,154GR,180D,208G,225A
JF320559	502-0364_wg5	USA	Feb-2007	genomic RNA	plasma from male placebo recipient502-0364	subtype: B	1	231	6V,27I,41T,68I,75D,83T,91V,120H,128D,180D,208G,225A
JF320322	502-0388_LH01	USA	Jan-2007	genomic RNA	plasma from male placebo recipient502-0388	subtype: B	1	231	91V,194S,208G,230I
JF320316	502-0388_LH02	USA	Jan-2007	genomic RNA	plasma from male placebo recipient502-0388	subtype: B	1	231	91V,194S,208G,230I
JF320326	502-0388_LH03	USA	Jan-2007	genomic RNA	plasma from male placebo recipient502-0388	subtype: B	1	231	91V,194S,208G,230I
JF320319	502-0388_LH04	USA	Jan-2007	genomic RNA	plasma from male placebo recipient502-0388	subtype: B	1	231	91V,194S,208G,230I
JF320321	502-0388_LH05	USA	Jan-2007	genomic RNA	plasma from male placebo recipient502-0388	subtype: B	1	231	91V,194S,208G,230I
JF320209	502-0491_wg1	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0491	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,110N,120S,154K,171V,180D,194S
JF320187	502-0491_wg3	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0491	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,110N,120S,154K,171V,180D,194S
JF320212	502-0491_wg4	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0491	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,110N,120S,154K,171V,180D,194S
JF320183	502-0491_wg5	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0491	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,110N,120S,154K,171V,180D,183T,194S
JF320224	502-0524_FL01	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0524	subtype: B	1	231	6L,14P,76X,79D,83L,87Q,91V,154K,171V,180D
JF320221	502-0524_FL02	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0524	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,154K,171V,180D
JF320203	502-0524_FL03	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0524	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,154K,171V,180D
JF320008	502-0524_FL04	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0524	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,154K,171V,180D
JF320009	502-0524_FL05	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0524	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,154K,171V,180D
JF320010	502-0524_FL06	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0524	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,154K,171V,180D
JF320219	502-0524_FL07	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0524	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,154K,171V,180D
JF320214	502-0524_FL08	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0524	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,154K,171V,180D
JF320222	502-0524_FL09	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0524	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,154K,171V,180D,198CR
JF320210	502-0524_FL10	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0524	subtype: B	1	231	6L,14P,79D,83L,87Q,91V,154K,171V,180D
JF320204	502-0525_wg1	Peru	Oct-2007	genomic RNA	plasma from male placebo recipient502-0525	subtype: B	1	231	6L,83L,180D
JF320195	502-0525_wg2	Peru	Oct-2007	genomic RNA	plasma from male placebo recipient502-0525	subtype: B	1	231	6L,83L,180D
JF320213	502-0525_wg3	Peru	Oct-2007	genomic RNA	plasma from male placebo recipient502-0525	subtype: B	1	231	6L,83L,180D
JF320199	502-0525_wg4	Peru	Oct-2007	genomic RNA	plasma from male placebo recipient502-0525	subtype: B	1	231	6L,39IM,83L,180D
JF320191	502-0525_wg5	Peru	Oct-2007	genomic RNA	plasma from male placebo recipient502-0525	subtype: B	1	231	6L,7QR,39IM,83L,180D
JF320041	502-0572_FL01	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0572	subtype: B	1	231	6L,83L,86P,87Q,91V,120S
JF320039	502-0572_FL02	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0572	subtype: B	1	231	6L,83L,86P,87Q,91V,120S
JF320042	502-0572_FL03	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0572	subtype: B	1	231	6L,83L,86P,87Q,91V,120S
JF320038	502-0572_FL06	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0572	subtype: B	1	231	6L,83L,86P,87Q,91V,120S
JF320040	502-0572_FL07	USA	May-2006	genomic RNA	plasma from male placebo recipient502-0572	subtype: B	1	231	6L,83L,86P,87Q,91V,120S
JF320215	502-0648_FL02	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0648	subtype: B	1	231	14P,68I,72V,83L,87Q,91V,96L,120H,128D,136M,154K,171V,180D
JF320186	502-0648_FL03	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0648	subtype: B	1	231	14P,46R,68I,72V,83L,87Q,91V,96L,120H,128D,136M,154K,171V,180D
JF320201	502-0648_FL04	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0648	subtype: B	1	231	14P,68I,72V,83L,87Q,91V,96L,120H,128D,136M,154K,171V,180D,230I
JF320193	502-0648_FL05	Peru	Aug-2006	genomic RNA	plasma from male vaccine recipient502-0648	subtype: B	1	231	14P,68I,72V,83L,87Q,91V,96L,120H,128D,136M,154K,171V,180D
JF320529	502-0717_FL01	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0717	subtype: B	1	231	6L,83L,87Q,91V,96L,120H,136M,141V
JF320526	502-0717_FL02	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0717	subtype: B	1	231	6L,83L,87Q,91V,96L,120H,136M,141V
JF320523	502-0717_LH01	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0717	subtype: B	1	231	6L,65V,83L,87Q,91V,96L,120H,136M,141V
JF320525	502-0717_LH02	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0717	subtype: B	1	231	6L,83L,87Q,91V,96L,120H,136M,141V
JF320522	502-0717_LH03	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0717	subtype: B	1	231	6L,83L,87Q,91V,96L,120H,136M,141V
JF320521	502-0717_LH04	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0717	subtype: B	1	231	6L,83L,87Q,91V,96L,120H,136M,141V
JF320346	502-0762_LH01	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-0762	subtype: B	1	231	6L,83L,148V,180D
JF320343	502-0762_LH02	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-0762	subtype: B	1	231	6L,83L,148V,180D
JF320334	502-0762_LH04	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-0762	subtype: B	1	231	6L,83L,148V,180D
JF320335	502-0762_LH05	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-0762	subtype: B	1	231	6L,83L,148V,180D
JF320344	502-0762_LH07	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-0762	subtype: B	1	231	6L,83L,148V,180D
JF320345	502-0762_LH08	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-0762	subtype: B	1	231	6L,83L,148V,180D
JF320347	502-0762_LH09	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-0762	subtype: B	1	231	6L,83L,148V,180D
JF320338	502-0762_LH10	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-0762	subtype: B	1	231	6L,78E,83L,148V,180D
JF320330	502-0762_LH11	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-0762	subtype: B	1	231	6L,83L,148V,180D
JF320341	502-0762_LH13	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-0762	subtype: B	1	231	6L,83L,148V,180D
JF320533	502-0823_01	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-0823	subtype: B	1	231	6L,41T,83L,87Q,96I,110N,116A,154K
JF320532	502-0823_02	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-0823	subtype: B	1	231	6L,41T,83L,87Q,96I,110N,116A,154K
JF320535	502-0823_03	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-0823	subtype: B	1	231	6L,41T,83L,87Q,96I,110N,116A,154K
JF320531	502-0823_04	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-0823	subtype: B	1	231	6L,41T,83L,87Q,96I,110N,116A,154K
JF320530	502-0823_05	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-0823	subtype: B	1	231	6L,41T,83L,87Q,96I,110N,116A,154K
JF320534	502-0823_06	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-0823	subtype: B	1	231	6L,10T,15L,41T,83L,87Q,96I,110N,116A,154K
JF320536	502-0823_07	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-0823	subtype: B	1	231	6L,41T,83L,87Q,96I,110N,116A,154K
JF320264	502-0839_LH01	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320266	502-0839_LH02	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320270	502-0839_LH03	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,116R,120H,148V
JF320262	502-0839_LH04	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320063	502-0839_LH05	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320260	502-0839_LH06	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320258	502-0839_LH07	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320263	502-0839_wg01	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320269	502-0839_wg02	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320268	502-0839_wg03	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320267	502-0839_wg04	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320271	502-0839_wg05	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0839	subtype: B	1	231	6L,15L,27I,83L,120H,148V
JF320196	502-0841_FL03	Peru	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0841	subtype: B	1	231	27I,68I,72V,83L,91V,107S,116E,128D,136M
JF320208	502-0841_FL04	Peru	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0841	subtype: B	1	231	27I,68I,72V,83L,91V,107S,116E,128D,136M
JF320218	502-0841_FL05	Peru	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0841	subtype: B	1	231	27I,68I,72V,83L,91V,107S,116A,128D,136M
JF320223	502-0841_FL07	Peru	Nov-2006	genomic RNA	plasma from male vaccine recipient502-0841	subtype: B	1	231	27I,68I,72V,83L,91V,107S,116E,128D,136M
JF320074	502-0879_LH_1	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-0879	subtype: B	1	231	6L,83L,110N,154K
JF320078	502-0879_LH_2	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-0879	subtype: B	1	231	6L,83L,110N,154K
JF320079	502-0879_LH_3	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-0879	subtype: B	1	231	6L,83L,110N,154K
JF320075	502-0879_LH_4	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-0879	subtype: B	1	231	6L,83L,110N,154K
JF320073	502-0879_LH_5	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-0879	subtype: B	1	231	6L,83L,110N,154K
JF320505	502-0897_LH02	USA	Dec-2006	genomic RNA	plasma from male vaccine recipient502-0897	subtype: B	1	231	6M,27I,31N,59I,75D,83L,86A,87Q,91A,96V,116A,120H,194S
JF320507	502-0897_LH03	USA	Dec-2006	genomic RNA	plasma from male vaccine recipient502-0897	subtype: B	1	231	6M,27I,31N,59I,75D,83L,86A,87Q,91A,96V,116A,120H,194S
JF320494	502-0897_LH04	USA	Dec-2006	genomic RNA	plasma from male vaccine recipient502-0897	subtype: B	1	231	6M,27I,31N,59I,75D,83L,86A,87Q,91A,96V,116A,120H,194S
JF320496	502-0897_LH05	USA	Dec-2006	genomic RNA	plasma from male vaccine recipient502-0897	subtype: B	1	231	6M,27I,31N,59I,75D,83L,86A,87Q,91A,96V,116A,120H,194S
JF320498	502-0897_LH07	USA	Dec-2006	genomic RNA	plasma from male vaccine recipient502-0897	subtype: B	1	231	6M,27I,31N,59I,75D,83L,86A,87Q,91A,96V,116A,120H,194S
JF320504	502-0897_LH08	USA	Dec-2006	genomic RNA	plasma from male vaccine recipient502-0897	subtype: B	1	231	6M,27I,31N,59I,75D,83L,86A,87Q,91A,96V,116A,120H,194S
JF320495	502-0897_LH10	USA	Dec-2006	genomic RNA	plasma from male vaccine recipient502-0897	subtype: B	1	231	6M,27I,31N,59I,75D,83L,86A,87Q,91A,96V,116A,120H,194S
JF320501	502-0897_LH11	USA	Dec-2006	genomic RNA	plasma from male vaccine recipient502-0897	subtype: B	1	231	6M,27I,31N,59I,75D,83L,86A,87Q,91A,96V,116A,120H,194S
JF320511	502-0897_LH12	USA	Dec-2006	genomic RNA	plasma from male vaccine recipient502-0897	subtype: B	1	231	6M,27I,31N,59I,75D,83L,86A,87Q,91A,96V,116A,120H,194S
JF320493	502-0897_LH13	USA	Dec-2006	genomic RNA	plasma from male vaccine recipient502-0897	subtype: B	1	231	6M,27I,31N,59I,75D,83L,86A,87Q,91A,96V,116A,120H,194S
JF320162	502-0923_wg01	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0923	subtype: B	1	231	6L,83L,120H,230I
JF320163	502-0923_wg02	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0923	subtype: B	1	231	2T,6L,83L,120H,230I
JF320165	502-0923_wg03	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0923	subtype: B	1	231	6L,83L,120H,230I
JF320161	502-0923_wg04	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0923	subtype: B	1	231	6L,83L,120H,230I
JF320167	502-0923_wg05	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0923	subtype: B	1	231	6L,83L,120H,230I
JF320166	502-0923_wg06	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0923	subtype: B	1	231	6L,83L,120H,230I
JF320160	502-0923_wg07	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0923	subtype: B	1	231	6L,83L,120H,230I
JF320164	502-0923_wg08	USA	Jul-2006	genomic RNA	plasma from male placebo recipient502-0923	subtype: B	1	231	6L,83L,120H,230I
JF320641	502-0938_LH01	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-0938	subtype: B	1	231	6L,14P,15L,41T,83M,120S,123A,180D
JF320639	502-0938_LH02	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-0938	subtype: B	1	231	6L,14P,16A,83M,120S,123A,180D
JF320640	502-0938_LH03	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-0938	subtype: B	1	231	6L,14P,16A,83M,120S,123A,180D
JF320634	502-0938_LH04	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-0938	subtype: B	1	231	6L,14P,41T,83M,120S,123A,180D
JF320355	502-0961_LH01	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0961	subtype: B	1	231	6L,14T,27I,83T,120H,148V,180D
JF320370	502-0961_LH02	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0961	subtype: B	1	231	6L,14T,27I,83T,120H,148V,180D
JF320359	502-0961_LH03	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0961	subtype: B	1	231	6L,14T,27I,83T,120H,148V,180D
JF320372	502-0961_LH04	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0961	subtype: B	1	231	6L,14T,27I,83T,120H,148V,180D,225S
JF320349	502-0961_LH05	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0961	subtype: B	1	231	6L,14T,27I,83T,120H,148V,180D
JF320352	502-0961_LH06	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0961	subtype: B	1	231	6L,14T,27I,83T,120H,148V,180D
JF320371	502-0961_LH07	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0961	subtype: B	1	231	6L,14T,27I,83T,120H,148V,180D
JF320362	502-0961_LH08	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0961	subtype: B	1	231	6L,14T,27I,83T,120H,148V,180D
JF320378	502-0961_LH09	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0961	subtype: B	1	231	6L,14T,27I,83T,120H,148V,180D
JF320357	502-0961_LH11	USA	Apr-2006	genomic RNA	plasma from male vaccine recipient502-0961	subtype: B	1	231	6L,14T,27I,83T,116R,120H,148V,180D
JF320384	502-0965_LH02	USA	Mar-2007	genomic RNA	plasma from male placebo recipient502-0965	subtype: B	1	231	6L,83L,154K
JF320381	502-0965_LH03	USA	Mar-2007	genomic RNA	plasma from male placebo recipient502-0965	subtype: B	1	231	6L,83L,154K
JF320413	502-1027_wg01	Canada	Oct-2006	genomic RNA	plasma from male placebo recipient502-1027	subtype: B	1	231	6L,83L,91V,136M,225S
JF320411	502-1027_wg02	Canada	Oct-2006	genomic RNA	plasma from male placebo recipient502-1027	subtype: B	1	231	6L,83L,91V,136M,225S
JF320419	502-1027_wg03	Canada	Oct-2006	genomic RNA	plasma from male placebo recipient502-1027	subtype: B	1	231	6L,83L,91V,136M,225S
JF320416	502-1027_wg04	Canada	Oct-2006	genomic RNA	plasma from male placebo recipient502-1027	subtype: B	1	231	6L,83L,91V,136M,225S
JF320418	502-1027_wg05	Canada	Oct-2006	genomic RNA	plasma from male placebo recipient502-1027	subtype: B	1	231	6L,83L,91V,136M,225S
JF320420	502-1027_wg06	Canada	Oct-2006	genomic RNA	plasma from male placebo recipient502-1027	subtype: B	1	231	6L,83L,91V,136M,225S
JF320415	502-1027_wg07	Canada	Oct-2006	genomic RNA	plasma from male placebo recipient502-1027	subtype: B	1	231	6L,83L,91V,136M,225S
JF320414	502-1027_wg09	Canada	Oct-2006	genomic RNA	plasma from male placebo recipient502-1027	subtype: B	1	231	6L,83L,91V,136M,225S
JF320412	502-1027_wg10	Canada	Oct-2006	genomic RNA	plasma from male placebo recipient502-1027	subtype: B	1	231	6L,83L,91V,136M,225S
JF320417	502-1027_wg11	Canada	Oct-2006	genomic RNA	plasma from male placebo recipient502-1027	subtype: B	1	231	6L,83L,91V,136M,225S
JF320566	502-1046_FL01	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-1046	subtype: B	1	231	6L,15L,41T,91V,110N,116A,120S,180D,208G
JF320568	502-1046_FL02	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-1046	subtype: B	1	231	6L,15L,41T,91V,110N,116A,120S,180D,208G
JF320567	502-1046_FL03	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-1046	subtype: B	1	231	6L,15L,41T,91V,110N,116A,120S,180D,208G
JF320564	502-1046_FL04	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-1046	subtype: B	1	231	6L,15L,41T,91V,110N,116A,120S,180D,208G
JF320565	502-1046_FL05	USA	Nov-2006	genomic RNA	plasma from male vaccine recipient502-1046	subtype: B	1	231	6L,15L,41T,91V,110N,116A,120S,180D,208G
JF320227	502-1047_wg1	Peru	Jan-2007	genomic RNA	plasma from male placebo recipient502-1047	subtype: B	1	231	4R,6L,83L,96L,116A,128D,132G,154K,225S
JF320225	502-1047_wg2	Peru	Jan-2007	genomic RNA	plasma from male placebo recipient502-1047	subtype: B	1	231	4R,6L,83L,96L,116A,128D,132G,154K,225S
JF320216	502-1047_wg3	Peru	Jan-2007	genomic RNA	plasma from male placebo recipient502-1047	subtype: B	1	231	4R,6L,83L,96L,116A,128D,132G,154K,225S
JF320198	502-1047_wg4	Peru	Jan-2007	genomic RNA	plasma from male placebo recipient502-1047	subtype: B	1	231	4R,6L,83L,96L,116A,128D,132G,154K,225S
JF320226	502-1047_wg5	Peru	Jan-2007	genomic RNA	plasma from male placebo recipient502-1047	subtype: B	1	231	4R,6L,83L,96L,116A,128D,132G,154K,225S
JF320169	502-1055_FL01	USA	Jan-2006	genomic RNA	plasma from male vaccine recipient502-1055	subtype: B	1	231	6L,41T,70E,83L,96I,112A,115M,116A,118I,120G,124V,136M,199R
JF320171	502-1055_FL02	USA	Jan-2006	genomic RNA	plasma from male vaccine recipient502-1055	subtype: B	1	231	6L,41T,83L,96I,112A,115M,116A,118I,120G,124V,136M,199R
JF320045	502-1115_wg1	USA	Sep-2007	genomic RNA	plasma from female placebo recipient502-1115	subtype: B	1	231	6L,15L,83L,148V,180D
JF320069	502-1115_wg2	USA	Sep-2007	genomic RNA	plasma from female placebo recipient502-1115	subtype: B	1	231	6L,15L,83L,148V,180D
JF320052	502-1115_wg3	USA	Sep-2007	genomic RNA	plasma from female placebo recipient502-1115	subtype: B	1	231	6L,15L,83L,148V,180D
JF320070	502-1115_wg6	USA	Sep-2007	genomic RNA	plasma from female placebo recipient502-1115	subtype: B	1	231	6L,15L,83L,148V,180D
JF320051	502-1174_FL01	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-1174	subtype: B	1	231	6M,14P,44A,83L,86A,87Q,91V,96V,116A,120H,154K
JF320049	502-1174_FL02	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-1174	subtype: B	1	231	6M,14P,44A,83L,86A,87Q,91V,96V,116A,120H,154K
JF320064	502-1174_FL03	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-1174	subtype: B	1	231	6M,14P,44A,83L,86A,87Q,91V,96V,116A,120H,154K
JF320055	502-1174_FL04	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-1174	subtype: B	1	231	6M,14P,44A,83L,86A,87Q,91V,96V,116A,120H,154K
JF320058	502-1174_FL05	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-1174	subtype: B	1	231	6M,14P,44A,83L,86A,87Q,91V,96V,116A,120H,154K
JF320047	502-1174_FL06	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-1174	subtype: B	1	231	6M,14P,44A,83L,86A,87Q,91V,96V,116A,120H,154K
JF320044	502-1174_FL07	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-1174	subtype: B	1	231	6M,14P,44A,83L,86A,87Q,91V,96V,116A,120H,154K
JF320060	502-1174_FL08	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-1174	subtype: B	1	231	6M,14P,44A,83L,86A,87Q,91V,96V,116A,120H,154K
JF320053	502-1174_FL09	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-1174	subtype: B	1	231	6M,14P,44A,83L,86A,87Q,91V,96V,116A,120H,154K
JF320062	502-1174_FL11	USA	Feb-2006	genomic RNA	plasma from male vaccine recipient502-1174	subtype: B	1	231	6M,14P,44A,83L,86A,87Q,91V,96V,116A,120H,154K,216A
JF320422	502-1191_01	Canada	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1191	subtype: B	1	231	6L,15L,27I,83L,87Q,91V,98D,120H,148V,208G
JF320424	502-1191_03	Canada	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1191	subtype: B	1	231	6L,15L,27I,83L,87Q,91V,98D,120H,148V,208G
JF320423	502-1191_05	Canada	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1191	subtype: B	1	231	6L,15L,27I,83L,87Q,91V,98D,120H,148V,208G
JF320426	502-1191_06	Canada	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1191	subtype: B	1	231	6L,15L,27I,83L,87Q,91V,98D,120H,148V,208G
JF320425	502-1191_07	Canada	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1191	subtype: B	1	231	6L,15L,27I,83L,87Q,91V,98D,120H,148V,208G
JF320151	502-1211_FL01	USA	Aug-2006	genomic RNA	plasma from male vaccine recipient502-1211	subtype: B	1	231	6L,14P,41T,83L,110N,120S,180D,199R
JF320148	502-1211_FL02	USA	Aug-2006	genomic RNA	plasma from male vaccine recipient502-1211	subtype: B	1	231	6L,14P,41T,83L,110N,120S,180D,199R
JF320149	502-1211_FL03	USA	Aug-2006	genomic RNA	plasma from male vaccine recipient502-1211	subtype: B	1	231	6L,14P,41T,83L,110N,120S,180D,199R
JF320144	502-1211_FL04	USA	Aug-2006	genomic RNA	plasma from male vaccine recipient502-1211	subtype: B	1	231	6L,14P,41T,83L,110N,120S,180D,199R
JF320146	502-1211_FL05	USA	Aug-2006	genomic RNA	plasma from male vaccine recipient502-1211	subtype: B	1	231	6L,14P,41T,83L,110N,120S,180D,199R
JF320177	502-1368_LH01	USA	Aug-2007	genomic RNA	plasma from male vaccine recipient502-1368	subtype: B	1	231	6L,14P,15V,41A,83L,110N,116A,120S,124V,132K,154K
JF320174	502-1368_LH02	USA	Aug-2007	genomic RNA	plasma from male vaccine recipient502-1368	subtype: B	1	231	6L,14P,15V,41A,83L,110N,116A,120S,124V,132K,154K,225S,229K
JF320176	502-1368_LH03	USA	Aug-2007	genomic RNA	plasma from male vaccine recipient502-1368	subtype: B	1	231	6L,14P,15V,41A,83L,110N,116A,120S,124V,132K,154K,225S,229K
JF320015	502-1399_wg1	Peru	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1399	subtype: B	1	231	6L,41T,83L,91V,115V,120S,136M
JF320016	502-1399_wg3	Peru	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1399	subtype: B	1	231	6L,41T,83L,91V,115V,120S,136M
JF320013	502-1399_wg4	Peru	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1399	subtype: B	1	231	6L,41T,83L,91V,115V,120S,136M
JF320014	502-1399_wg5	Peru	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1399	subtype: B	1	231	6L,41T,83L,91V,115V,120S,136M
JF320012	502-1399_wg6	Peru	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1399	subtype: B	1	231	6L,41T,83L,91V,115V,120S,136M
JF320050	502-1400_FL01	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1400	subtype: B	1	231	6L,27I,41T,52I,83L,87Q,91V,98D,116A,120S,132K,136M,154K,178T,207T,208G,225A
JF320043	502-1400_FL02	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1400	subtype: B	1	231	6L,27I,41T,52I,83L,87Q,91V,98D,116A,120S,132K,136M,154K,178T,207T,208G,225A
JF320066	502-1400_FL03	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1400	subtype: B	1	231	6L,27I,41T,52I,83L,87Q,91V,98D,116A,120S,132K,136M,154K,178T,207T,208G,225A
JF320067	502-1400_FL04	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1400	subtype: B	1	231	6L,27I,41T,52I,83L,87Q,91V,98D,116A,120S,132K,136M,154K,178T,207T,208G,225A
JF320046	502-1400_FL05	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1400	subtype: B	1	231	6L,27I,41T,52I,83L,87Q,91V,98D,116A,120S,132K,136M,154K,178T,207T,208G,225A
JF320158	502-1478_wg1	USA	May-2007	genomic RNA	plasma from male placebo recipient502-1478	subtype: B	1	231	6S,27I,41T,50H,75D,83L,116A,118T,154K,178T,203R
JF320155	502-1478_wg2	USA	May-2007	genomic RNA	plasma from male placebo recipient502-1478	subtype: B	1	231	6S,27I,41T,50H,75D,83L,116A,118T,154K,178T,203R
JF320156	502-1478_wg3	USA	May-2007	genomic RNA	plasma from male placebo recipient502-1478	subtype: B	1	231	6S,27I,41T,50H,75D,83L,116A,118T,154K,178T,203R
JF320150	502-1478_wg4	USA	May-2007	genomic RNA	plasma from male placebo recipient502-1478	subtype: B	1	231	6S,27I,41T,50H,75D,83L,116A,118T,154K,178T,203R
JF320157	502-1478_wg5	USA	May-2007	genomic RNA	plasma from male placebo recipient502-1478	subtype: B	1	231	6S,27I,41T,50H,75D,83L,116A,118T,154K,178T,203R
JF320392	502-1500_LH01	USA	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1500	subtype: B	1	231	6L,83L,91V,154K,160S,178T,205M
JF320386	502-1500_LH02	USA	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1500	subtype: B	1	231	6L,83L,91V,154K,160S,178T
JF320389	502-1500_LH03	USA	Jan-2007	genomic RNA	plasma from male vaccine recipient502-1500	subtype: B	1	231	6L,83L,91V,154K,160S,178T,205M
JF320402	502-1504_LH01	USA	Nov-2007	genomic RNA	plasma from male placebo recipient502-1504	subtype: B	1	231	6L,14P,44A,83L,86A,116A,154K,170R,194S,225S
JF320437	502-1504_LH02	USA	Nov-2007	genomic RNA	plasma from male placebo recipient502-1504	subtype: B	1	231	6L,14P,44A,83L,116A,154K,170R,194S,225S
JF320439	502-1504_LH03	USA	Nov-2007	genomic RNA	plasma from male placebo recipient502-1504	subtype: B	1	231	6L,14P,44A,83L,116A,154K,170R,194S,225S
JF320401	502-1504_LH04	USA	Nov-2007	genomic RNA	plasma from male placebo recipient502-1504	subtype: B	1	231	6L,14P,44A,83L,116A,154K,170R,194S,225S
JF320432	502-1504_LH05	USA	Nov-2007	genomic RNA	plasma from male placebo recipient502-1504	subtype: B	1	231	6L,14P,44A,83L,116A,154K,170R,194S,225S
JF320404	502-1504_LH07	USA	Nov-2007	genomic RNA	plasma from male placebo recipient502-1504	subtype: B	1	231	6L,14P,44A,83M,110N,154K,170R,194S,225S
JF320405	502-1504_LH08	USA	Nov-2007	genomic RNA	plasma from male placebo recipient502-1504	subtype: B	1	231	6L,14P,44A,83L,116A,154K,170R,194S,225S
JF320421	502-1504_LH09	USA	Nov-2007	genomic RNA	plasma from male placebo recipient502-1504	subtype: B	1	231	6L,14P,44A,83L,116A,154K,170R,194S,225S
JF320410	502-1504_LH10	USA	Nov-2007	genomic RNA	plasma from male placebo recipient502-1504	subtype: B	1	231	6L,14P,44A,83L,116A,154K,170R,194S,225S
JF320356	502-1512_FL01	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,225S
JF320456	502-1512_LH01	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,225S
JF320441	502-1512_LH02	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,225S
JF320444	502-1512_LH03	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,225S
JF320446	502-1512_LH04	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,136M,225S
JF320459	502-1512_LH05	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,225S
JF320448	502-1512_LH06	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,225S
JF320457	502-1512_LH07	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,225S
JF320458	502-1512_LH08	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,136M,225S
JF320449	502-1512_LH09	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,190W,225S
JF320445	502-1512_LH10	USA	Sep-2006	genomic RNA	plasma from male vaccine recipient502-1512	subtype: B	1	231	6L,83L,225S
JF320109	502-1518_LH02	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-1518	subtype: B	1	231	6L,27I,83L,98D,148V
JF320112	502-1518_LH03	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-1518	subtype: B	1	231	6L,27I,83L,98D,148V
JF320118	502-1518_LH04	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-1518	subtype: B	1	231	6L,27I,83L,98D,148V
JF320108	502-1518_LH05	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-1518	subtype: B	1	231	6L,27I,83L,148V
JF320105	502-1518_LH06	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-1518	subtype: B	1	231	6L,27I,83L,98D,148V
JF320113	502-1518_LH07	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-1518	subtype: B	1	231	6L,27I,83L,98D,148V
JF320104	502-1518_LH08	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-1518	subtype: B	1	231	6L,27I,83L,98D,148V
JF320101	502-1518_LH09	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-1518	subtype: B	1	231	6L,27I,83L,148V
JF320115	502-1518_LH10	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-1518	subtype: B	1	231	6L,27I,83L,98D,148V
JF320102	502-1518_LH11	USA	Jun-2007	genomic RNA	plasma from male placebo recipient502-1518	subtype: B	1	231	6L,27I,83L,98D,148V
JF320123	502-1619_FL01	USA	May-2006	genomic RNA	plasma from male vaccine recipient502-1619	subtype: B	1	231	6L,15L,27I,96L,110N,116A,120H,148V,178T,208G,225A
JF320129	502-1619_FL02	USA	May-2006	genomic RNA	plasma from male vaccine recipient502-1619	subtype: B	1	231	6L,15L,27I,96L,110N,116A,120H,148V,178T,208G,225A
JF320122	502-1619_FL03	USA	May-2006	genomic RNA	plasma from male vaccine recipient502-1619	subtype: B	1	231	6L,15L,27I,96L,110N,116A,120H,148V,178T,208G,225A
JF320127	502-1619_FL04	USA	May-2006	genomic RNA	plasma from male vaccine recipient502-1619	subtype: B	1	231	6L,15L,27I,96L,110N,116A,120H,148V,178T,208G,225A
JF320125	502-1619_FL05	USA	May-2006	genomic RNA	plasma from male vaccine recipient502-1619	subtype: B	1	231	6L,15L,27I,96L,110N,116A,120H,148V,178T,208G,225A
JF320126	502-1619_FL06	USA	May-2006	genomic RNA	plasma from male vaccine recipient502-1619	subtype: B	1	231	6L,15L,27I,96L,110N,116A,120H,148V,178T,208G,225A
JF320128	502-1619_FL07	USA	May-2006	genomic RNA	plasma from male vaccine recipient502-1619	subtype: B	1	231	6L,15L,27I,96L,110N,116A,120H,148V,178T,208G,225A
JF320121	502-1619_FL08	USA	May-2006	genomic RNA	plasma from male vaccine recipient502-1619	subtype: B	1	231	6L,15L,27I,96L,110N,116A,120H,148V,178T,208G,225A
JF320120	502-1619_FL09	USA	May-2006	genomic RNA	plasma from male vaccine recipient502-1619	subtype: B	1	231	6L,15L,27I,96L,110N,116A,120H,148V,178T,208G,225A
JF320124	502-1619_FL10	USA	May-2006	genomic RNA	plasma from male vaccine recipient502-1619	subtype: B	1	231	6L,15L,27I,96L,110N,116A,120H,148V,178T,208G,225A
JF320466	502-1709_02	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,180D
JF320468	502-1709_03	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,180D
JF320467	502-1709_04	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,180D
JF320462	502-1709_06	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,180D
JF320460	502-1709_07	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,180D
JF320469	502-1709_08	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,180D
JF320464	502-1709_09	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,180D
JF320461	502-1709_10	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,180D
JF320465	502-1709_11	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,120H,180D
JF320470	502-1709_12	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,180D
JF320463	502-1709_14	USA	Oct-2007	genomic RNA	plasma from male vaccine recipient502-1709	subtype: B	1	231	6L,75D,83L,180D
JF320429	502-1799_FL01	Canada	Mar-2006	genomic RNA	plasma from male placebo recipient502-1799	subtype: B	1	231	6L,15L,41T,83L,96L,116A,120H,148A,180D,208G,210S
JF320427	502-1799_FL02	Canada	Mar-2006	genomic RNA	plasma from male placebo recipient502-1799	subtype: B	1	231	6L,15L,41T,83L,96L,116A,120H,148A,180D,208G,210S
JF320428	502-1799_FL03	Canada	Mar-2006	genomic RNA	plasma from male placebo recipient502-1799	subtype: B	1	231	6L,15L,41T,83L,96L,116A,120H,148A,180D,208G,210S
JF320431	502-1799_FL04	Canada	Mar-2006	genomic RNA	plasma from male placebo recipient502-1799	subtype: B	1	231	6L,15L,41T,83L,96L,116A,120H,148A,180D,208G,210S
JF320430	502-1799_FL05	Canada	Mar-2006	genomic RNA	plasma from male placebo recipient502-1799	subtype: B	1	231	6L,15L,41T,83L,96L,116A,120H,148A,180D,208G,210S
JF320179	502-1897_wg2	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-1897	subtype: B	1	231	6L,14P,16A,79D,83L,87Q,91V,120S,154K,180D
JF320181	502-1897_wg4	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-1897	subtype: B	1	231	6L,14P,16A,79D,83L,87Q,91V,120S,154K,180D
JF320182	502-1897_wg6	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-1897	subtype: B	1	231	6L,14P,16A,79D,83L,87Q,91V,120S,154K,180D
JF320180	502-1897_wg7	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-1897	subtype: B	1	231	6L,14P,16A,79D,83L,87Q,91V,120S,154K,180D
JF320178	502-1897_wg8	USA	May-2007	genomic RNA	plasma from male vaccine recipient502-1897	subtype: B	1	231	6L,14P,16A,79D,83L,87Q,91V,110A,120S,154K,180D
JF320361	502-1926_FL01	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1926	subtype: B	1	231	14P,41A,83M,91V,101E,132K,136M
JF320483	502-1926_FL02	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1926	subtype: B	1	231	14P,41A,83M,91V,132K,136M
JF320478	502-1926_FL03	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1926	subtype: B	1	231	14P,41A,83M,91V,132K,136M
JF320477	502-1926_FL04	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1926	subtype: B	1	231	14P,41A,83M,91V,132K,136M
JF320481	502-1926_LH03	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1926	subtype: B	1	231	14P,41A,83M,91V,132K,136M
JF320472	502-1926_LH04	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1926	subtype: B	1	231	14P,41A,83M,91V,132K,136M
JF320476	502-1926_LH05	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1926	subtype: B	1	231	14P,41A,83M,91V,132K,136M
JF320480	502-1926_LH06	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1926	subtype: B	1	231	14P,41A,83M,91V,132K,136M
JF320471	502-1926_LH07	USA	Jun-2005	genomic RNA	plasma from male vaccine recipient502-1926	subtype: B	1	231	14P,41A,83M,91V,132K,136M
JF320277	502-2000_LH01	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2000	subtype: B	1	231	6L,14P,15M,27I,83M,91V,116A,120S,123S,180D
JF320292	502-2000_LH02	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2000	subtype: B	1	231	6L,14P,15M,27I,83M,91V,116A,120S,123S,180D
JF320283	502-2000_LH03	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2000	subtype: B	1	231	6L,14P,15M,27I,83M,91V,116A,120S,123S,180D
JF320281	502-2000_LH04	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2000	subtype: B	1	231	6L,14P,15M,27I,83M,91V,116A,120S,123S,180D
JF320278	502-2000_LH05	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2000	subtype: B	1	231	6L,14P,15M,27I,83M,91V,116A,120S,123S,180D
JF320284	502-2000_LH06	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2000	subtype: B	1	231	6L,14P,15M,27I,83M,91V,116A,120S,123S,180D
JF320287	502-2000_LH08	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2000	subtype: B	1	231	6L,14P,15M,27I,83M,91V,116A,120S,123S,180D
JF320290	502-2000_LH09	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2000	subtype: B	1	231	6L,14P,15M,27I,83I,91V,116A,120S,123S,180D
JF320280	502-2000_LH10	USA	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2000	subtype: B	1	231	6L,14P,15M,27I,83M,91V,116A,120S,123S,180D
JF320487	502-2008_FL01	USA	Apr-2005	genomic RNA	plasma from male placebo recipient502-2008	subtype: B	1	231	6L,27I,83T,87Q,91V,96V,116A,120H,148V,178T
JF320490	502-2008_FL02	USA	Apr-2005	genomic RNA	plasma from male placebo recipient502-2008	subtype: B	1	231	6L,27I,83T,87Q,91V,96V,116A,120H,148V,178T
JF320486	502-2008_FL03	USA	Apr-2005	genomic RNA	plasma from male placebo recipient502-2008	subtype: B	1	231	6L,27I,83T,87Q,91V,96V,116A,120H,148V,178T
JF320484	502-2008_FL04	USA	Apr-2005	genomic RNA	plasma from male placebo recipient502-2008	subtype: B	1	231	6L,27I,83T,87Q,91V,96V,116A,120H,148V,178T
JF320492	502-2008_FL07	USA	Apr-2005	genomic RNA	plasma from male placebo recipient502-2008	subtype: B	1	231	6L,27I,83T,87Q,91V,96V,116A,120H,148V,178T
JF320485	502-2008_FL08	USA	Apr-2005	genomic RNA	plasma from male placebo recipient502-2008	subtype: B	1	231	6L,27I,83T,87Q,91V,96I,116A,120H,148V,178T
JF320491	502-2008_FL09	USA	Apr-2005	genomic RNA	plasma from male placebo recipient502-2008	subtype: B	1	231	6L,27I,83T,87Q,91V,96V,116A,120H,148V,178T
JF320488	502-2008_FL10	USA	Apr-2005	genomic RNA	plasma from male placebo recipient502-2008	subtype: B	1	231	6L,27I,83T,87Q,91V,96V,116A,120H,148V,178T
JF320489	502-2008_FL11	USA	Apr-2005	genomic RNA	plasma from male placebo recipient502-2008	subtype: B	1	231	6L,27I,83T,87Q,91V,96V,116A,120H,148V,178T
JF320482	502-2008_FL12	USA	Apr-2005	genomic RNA	plasma from male placebo recipient502-2008	subtype: B	1	231	6L,27I,83T,87Q,91V,96V,116A,120H,148V,178T
JF320194	502-2136_FL01	USA	Sep-2005	genomic RNA	plasma from male vaccine recipient502-2136	subtype: B	1	231	6M,15M,27I,41A,83M,91V,120S,124V,154K,178T
JF320185	502-2136_FL02	USA	Sep-2005	genomic RNA	plasma from male vaccine recipient502-2136	subtype: B	1	231	6M,15M,27I,41A,83I,91V,98K,120S,124V,154K,178T
JF320188	502-2136_FL03	USA	Sep-2005	genomic RNA	plasma from male vaccine recipient502-2136	subtype: B	1	231	6M,15M,27I,41A,83M,91V,120S,124V,154K,178T
JF320192	502-2136_FL04	USA	Sep-2005	genomic RNA	plasma from male vaccine recipient502-2136	subtype: B	1	231	6M,15M,27I,41A,83M,91V,120S,124V,154K,178T
JF320190	502-2136_FL05	USA	Sep-2005	genomic RNA	plasma from male vaccine recipient502-2136	subtype: B	1	231	6M,15M,27I,41A,83M,91V,120S,124V,154K,178T
JF320544	502-2241_LH01	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,79D,83L,87Q,91V,120S,148V,180D,208G
JF320537	502-2241_LH02	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,62HR,79D,83L,87Q,91V,120S,148V,180D,208G
JF320540	502-2241_LH03	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,79D,83L,87Q,91V,120S,148V,180D,208G
JF320551	502-2241_LH04	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,79D,83L,87Q,91V,120S,148V,180D,208G
JF320549	502-2241_LH05	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,79D,83L,87Q,91V,120S,148V,180D,208G
JF320545	502-2241_LH06	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,79D,83L,87Q,91V,120S,148V,180D,208G
JF320553	502-2241_LH07	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,79D,83L,87Q,91V,120S,148V,180D,208G
JF320538	502-2241_LH08	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,79D,83L,87Q,91V,120S,148V,165I,180D,208G
JF320542	502-2241_LH09	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,79D,83L,87Q,91V,120S,148V,180D,208G
JF320550	502-2241_LH10	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,79D,83L,87Q,91V,120S,148V,180D,208G
JF320552	502-2241_LH11	USA	Feb-2007	genomic RNA	plasma from male vaccine recipient502-2241	subtype: B	1	231	14P,27I,79D,83L,87Q,91V,120S,148V,180D,208G
JF320024	502-2254_FL1	Peru	Dec-2007	genomic RNA	plasma from male vaccine recipient502-2254	subtype: B	1	231	6S,15L,27I,30R,50H,83L,110N,154K,210S,216S,225A
JF320020	502-2254_FL2	Peru	Dec-2007	genomic RNA	plasma from male vaccine recipient502-2254	subtype: B	1	231	6S,15L,27I,30R,50H,83L,110N,154K,210S,216S,225A
JF320023	502-2254_FL3	Peru	Dec-2007	genomic RNA	plasma from male vaccine recipient502-2254	subtype: B	1	231	6S,15L,27I,30R,50H,83L,110N,148I,154K,210S,216S,225A
JF320026	502-2254_FL4	Peru	Dec-2007	genomic RNA	plasma from male vaccine recipient502-2254	subtype: B	1	231	6S,15L,27I,30R,50H,83L,110N,154K,210S,216S,225A
JF320021	502-2254_FL5	Peru	Dec-2007	genomic RNA	plasma from male vaccine recipient502-2254	subtype: B	1	231	6S,15L,27I,30R,50H,83L,110N,154K,210S,216S,225A
JF320018	502-2254_FL6	Peru	Dec-2007	genomic RNA	plasma from male vaccine recipient502-2254	subtype: B	1	231	6S,15L,27I,30R,50H,83L,91IT,110N,154K,210S,216S,225A
JF320202	502-2289_02	USA	Jul-2007	genomic RNA	plasma from male vaccine recipient502-2289	subtype: B	1	231	6V,27I,83L,120H,148V,154K,178T
JF320205	502-2289_03	USA	Jul-2007	genomic RNA	plasma from male vaccine recipient502-2289	subtype: B	1	231	6V,27I,83L,120H,148V,154K,178T
JF320207	502-2289_04	USA	Jul-2007	genomic RNA	plasma from male vaccine recipient502-2289	subtype: B	1	231	6V,27I,83L,120H,148V,154K,178T
JF320197	502-2289_05	USA	Jul-2007	genomic RNA	plasma from male vaccine recipient502-2289	subtype: B	1	231	6V,27I,83L,120H,148V,154K,178T
JF320200	502-2289_06	USA	Jul-2007	genomic RNA	plasma from male vaccine recipient502-2289	subtype: B	1	231	6V,27I,83L,120H,148V,154K,178T
JF320577	502-2305_01	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,178T
JF320409	502-2305_LH02	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,178T
JF320573	502-2305_LH03	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,178T
JF320574	502-2305_LH04	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,178T
JF320572	502-2305_LH05	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,119M,178T
JF320591	502-2305_LH07	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,178T
JF320576	502-2305_LH08	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,178T
JF320582	502-2305_LH09	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,178T
JF320575	502-2305_LH10	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,178T
JF320571	502-2305_LH11	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,178T
JF320569	502-2305_LH12	USA	Jun-2007	genomic RNA	plasma from male vaccine recipient502-2305	subtype: B	1	231	6L,83L,178T
JF320028	502-2349_wg2	Peru	Jan-2007	genomic RNA	plasma from male vaccine recipient502-2349	subtype: B	1	231	6L,68I,79D,83L,120S,180D,225S
JF320031	502-2349_wg4	Peru	Jan-2007	genomic RNA	plasma from male vaccine recipient502-2349	subtype: B	1	231	6L,68I,79D,83L,120S,180D,225S
JF320032	502-2349_wg5	Peru	Jan-2007	genomic RNA	plasma from male vaccine recipient502-2349	subtype: B	1	231	6L,68I,79D,83L,120S,180D,225S
JF320029	502-2349_wg9	Peru	Jan-2007	genomic RNA	plasma from male vaccine recipient502-2349	subtype: B	1	231	6L,68I,79D,83L,120S,180D,225S
JF320596	502-2437_LH01	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320611	502-2437_LH02	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320595	502-2437_LH03	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320601	502-2437_LH04	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320610	502-2437_LH05	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320599	502-2437_LH06	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320612	502-2437_LH07	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320594	502-2437_LH08	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320600	502-2437_LH09	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320608	502-2437_LH10	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320604	502-2437_LH11	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320603	502-2437_LH12	USA	Jul-2006	genomic RNA	plasma from male vaccine recipient502-2437	subtype: B	1	231	6L,41A,83L,116A,132K,136M,225S
JF320057	502-2495_wg01	USA	Dec-2005	genomic RNA	plasma from male placebo recipient502-2495	subtype: B	1	231	6S,15L,50H,83L,91V,110N,194S
JF320054	502-2495_wg02	USA	Dec-2005	genomic RNA	plasma from male placebo recipient502-2495	subtype: B	1	231	6S,15L,50H,83L,91V,110N,194S
JF320061	502-2495_wg03	USA	Dec-2005	genomic RNA	plasma from male placebo recipient502-2495	subtype: B	1	231	6S,15L,50H,83L,91V,110N,194S
JF320133	502-2586_LH01	USA	Apr-2007	genomic RNA	plasma from male placebo recipient502-2586	subtype: B	1	231	6L,83L
JF320138	502-2586_LH02	USA	Apr-2007	genomic RNA	plasma from male placebo recipient502-2586	subtype: B	1	231	6L,83L,96I
JF320137	502-2586_LH03	USA	Apr-2007	genomic RNA	plasma from male placebo recipient502-2586	subtype: B	1	231	6L,83L
JF320140	502-2586_LH04	USA	Apr-2007	genomic RNA	plasma from male placebo recipient502-2586	subtype: B	1	231	6L,83L,96I
JF320143	502-2586_LH05	USA	Apr-2007	genomic RNA	plasma from male placebo recipient502-2586	subtype: B	1	231	6L,83L,96I
JF320139	502-2586_LH06	USA	Apr-2007	genomic RNA	plasma from male placebo recipient502-2586	subtype: B	1	231	6L,83L
JF320132	502-2586_LH07	USA	Apr-2007	genomic RNA	plasma from male placebo recipient502-2586	subtype: B	1	231	6L,83L
JF320130	502-2586_LH08	USA	Apr-2007	genomic RNA	plasma from male placebo recipient502-2586	subtype: B	1	231	6L,83L,96I
JF320189	502-2622_wg1	Peru	May-2007	genomic RNA	plasma from male placebo recipient502-2622	subtype: B	1	231	6A,33N,41A,68I,83L,110N,132K,136M,154K,225S
JF320217	502-2622_wg2	Peru	May-2007	genomic RNA	plasma from male placebo recipient502-2622	subtype: B	1	231	6A,33N,41A,68I,83L,110N,132K,136M,154K,225S
JF320206	502-2622_wg3	Peru	May-2007	genomic RNA	plasma from male placebo recipient502-2622	subtype: B	1	231	6A,33N,41A,68I,83L,110N,132K,136M,154K,225S
JF320220	502-2622_wg4	Peru	May-2007	genomic RNA	plasma from male placebo recipient502-2622	subtype: B	1	231	6A,33N,41A,68I,83L,110N,132K,136M,154K,225S
JF320211	502-2622_wg5	Peru	May-2007	genomic RNA	plasma from male placebo recipient502-2622	subtype: B	1	231	6A,33N,41A,68I,83L,110N,132K,136M,154K,225S
JF320034	502-2649_wg1	Peru	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2649	subtype: B	1	231	6L,14P,41T,72V,83L,180D,203R
JF320025	502-2649_wg10	Peru	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2649	subtype: B	1	231	6L,14P,41T,72V,83L,180D,203R
JF320017	502-2649_wg2	Peru	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2649	subtype: B	1	231	6L,14P,41T,72V,83L,160L,180D,203R
JF320030	502-2649_wg3	Peru	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2649	subtype: B	1	231	6L,14P,41T,72V,83L,180D,203R
JF320033	502-2649_wg4	Peru	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2649	subtype: B	1	231	6L,14P,41T,72V,83L,180D,203R
JF320027	502-2649_wg5	Peru	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2649	subtype: B	1	231	6L,14P,41T,72V,83L,180D,203R
JF320022	502-2649_wg7	Peru	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2649	subtype: B	1	231	6L,14P,41T,72V,83L,180D,203R
JF320019	502-2649_wg8	Peru	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2649	subtype: B	1	231	6L,14P,41T,72V,83L,180D,203R
JF320035	502-2649_wg9	Peru	Mar-2007	genomic RNA	plasma from male vaccine recipient502-2649	subtype: B	1	231	6L,14P,41T,72V,83L,180D,203R
JF320147	502-2667_FL01	USA	Jun-2006	genomic RNA	plasma from male placebo recipient502-2667	subtype: B	1	231	6L,83M,87Q,91V,110N,116A,120S,124V,136M,183H
JF320152	502-2667_FL02	USA	Jun-2006	genomic RNA	plasma from male placebo recipient502-2667	subtype: B	1	231	6L,83M,87Q,91V,110N,116A,120S,124V,136M,183H
JF320145	502-2667_FL03	USA	Jun-2006	genomic RNA	plasma from male placebo recipient502-2667	subtype: B	1	231	6L,83M,87Q,91V,110N,116A,120S,124V,136M,183H
JF320153	502-2667_FL04	USA	Jun-2006	genomic RNA	plasma from male placebo recipient502-2667	subtype: B	1	231	6L,83M,87Q,91V,110N,116A,120S,124V,136M,183H
JF320154	502-2667_FL05	USA	Jun-2006	genomic RNA	plasma from male placebo recipient502-2667	subtype: B	1	231	6L,83M,87Q,91V,110N,116A,120S,124V,136M,183H
JF320297	502-2696_FL01	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-2696	subtype: CRF02_AG	1	231	6A,10W,11T,14N,15M,27I,54M,58I,71D,120S,128D,154K,169F,178T,200A,203R,208G
JF320295	502-2696_LH01	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-2696	subtype: CRF02_AG	1	231	6A,10W,11T,14N,15M,27I,54M,58I,71D,120S,128D,154K,169F,178T,200A,203R,208G
JF320304	502-2696_LH02	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-2696	subtype: CRF02_AG	1	231	6A,10W,11T,14N,15M,27I,54M,58I,71D,120S,128D,154K,169F,178T,200A,203R,208G
JF320306	502-2696_LH03	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-2696	subtype: CRF02_AG	1	231	6A,10W,11T,14N,15M,27I,54M,58I,71D,100K,120S,128D,154K,169F,178T,200A,203R,208G
JF320299	502-2696_LH04	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-2696	subtype: CRF02_AG	1	231	6A,10W,11T,14N,15M,27I,54M,58I,71D,120S,128D,154K,169F,178T,200A,203R,208G
JF320302	502-2696_LH05	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-2696	subtype: CRF02_AG	1	231	6A,10W,11T,14N,15M,27I,54M,58I,71D,120S,128D,154K,169F,178T,200A,203R,208G
JF320298	502-2696_LH06	USA	Jun-2006	genomic RNA	plasma from male vaccine recipient502-2696	subtype: CRF02_AG	1	231	6A,10W,11T,14N,15M,27I,54M,58I,71D,120S,128D,154K,169F,178T,200A,203R,208G
JF320239	502-2717_LH01	Peru	Oct-2006	genomic RNA	plasma from male vaccine recipient502-2717	subtype: B	1	231	6L,72V,83L,136M
JF320229	502-2717_LH02	Peru	Oct-2006	genomic RNA	plasma from male vaccine recipient502-2717	subtype: B	1	231	6L,72V,83L,136M
JF320240	502-2717_LH03	Peru	Oct-2006	genomic RNA	plasma from male vaccine recipient502-2717	subtype: B	1	231	6L,72V,83L,136M
JF320234	502-2717_LH04	Peru	Oct-2006	genomic RNA	plasma from male vaccine recipient502-2717	subtype: B	1	231	6L,72V,83L,136M
JF320228	502-2717_LH05	Peru	Oct-2006	genomic RNA	plasma from male vaccine recipient502-2717	subtype: B	1	231	6L,72V,83L,136M
JF320236	502-2717_LH06	Peru	Oct-2006	genomic RNA	plasma from male vaccine recipient502-2717	subtype: B	1	231	6L,72V,83L,136M
JF320241	502-2794_FL01	Peru	Aug-2006	genomic RNA	plasma from male placebo recipient502-2794	subtype: B	1	231	6L,27I,71D,83L,148V,180D
JF320243	502-2794_FL02	Peru	Aug-2006	genomic RNA	plasma from male placebo recipient502-2794	subtype: B	1	231	6L,27I,71D,83L,148V,180D
JF320242	502-2794_FL03	Peru	Aug-2006	genomic RNA	plasma from male placebo recipient502-2794	subtype: B	1	231	6L,27I,71D,83L,148V,180D
JF320245	502-2794_FL04	Peru	Aug-2006	genomic RNA	plasma from male placebo recipient502-2794	subtype: B	1	231	6L,27I,71D,83L,148V,180D
JF320244	502-2794_FL05	Peru	Aug-2006	genomic RNA	plasma from male placebo recipient502-2794	subtype: B	1	231	6L,27I,71D,83L,148V,180D

Genbank References: capsid (p24)

Database

Resources

Team